Successful Use of Tocilizumab in a Patient with Coexisting Rheumatoid Arthritis and Ulcerative Colitis

Tocilizumab is an interleukin-6 receptor inhibitor licensed for moderate to severe rheumatoid arthritis (RA). We report a case of Tocilizumab monotherapy for severe active RA in a patient with coexisting ulcerative colitis (UC). The patient was intolerant to multiple disease-modifying drugs, so Toci...

Descripción completa

Detalles Bibliográficos
Autores principales: Szeto, Matthew Chak Hin, Yalçın, Metin Devrim, Khan, Abdul, Piotrowicz, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080477/
https://www.ncbi.nlm.nih.gov/pubmed/27818807
http://dx.doi.org/10.1155/2016/7562123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080477/
https://www.ncbi.nlm.nih.gov/pubmed/27818807
http://dx.doi.org/10.1155/2016/7562123

Ejemplares similares